In This Section

Newsroom

January 22, 2020
New Study by Temple Researchers Is the First to Show Pharmacological Chaperone Therapy Prevents Alzheimer’s Disease in Mice

In a new study, scientists at the Lewis Katz School of Medicine describe a novel pharmacological chaperone capable of preventing Alzheimer’s disease in animals prone to developing the condition.
- VIEW STORY
January 09, 2020
Common Genetic Defect in Prostate Cancer Inspires Path to New Anti-Cancer Drugs

A study led by Temple's Dr. Xavier Grana and published in the journal Oncogenesis is the first to show that re-expressing the protein B55/PP2A in affected cells can slow or stop the growth of prostate cancer cells in cellular and animal models.
- VIEW STORY
January 08, 2020
Narrative Medicine Takes Center Stage at First-Ever Temple Conference

The Lewis Katz School of Medicine was alive with storytelling on December 7. Not to mention poetry, dance, photography, improv and writing. All were part of the school’s inaugural Narrative Medicine Conference.
- VIEW STORY
January 07, 2020
Temple Receives Gift to Create the Scott Richards North Star Foundation and Stop Alzheimer’s Now Chair for Alzheimer’s Research

The Lewis Katz School of Medicine has received a gift from Temple University trustee, benefactor and Fox School of Business alumnus Phil Richards and the Scott Richards North Star Charitable Foundation, as well as Stop Alzheimer’s Now, to establish the Scott Richards North Star Foundation and Stop Alzheimer’s Now Chair for Alzheimer’s Research at the Alzheimer’s Center at Temple.
- VIEW STORY
December 20, 2019
Temple Burn Center Using Spray-On Skin™ Cells Technology to Offer Patients a New, Less Invasive Option for the Treatment of Severe Burns

Temple University Hospital is now treating patients with the RECELL® System, a Spray-On Skin™ Cells technology approved by the U.S. Food and Drug Administration in January 2019 for the treatment of acute thermal second and third-degree burns in adult patients.
- VIEW STORY
December 18, 2019
Temple and Jefferson Sign Definitive Agreement For Sale of Fox Chase Cancer Center to Jefferson and to Create Broad Affiliation

Temple University and Thomas Jefferson University today announced that the two institutions have entered into a binding Definitive Agreement for the acquisition by Jefferson of Fox Chase Cancer Center (FCCC), as well as Temple’s Bone Marrow Transplant program.
- VIEW STORY
December 09, 2019
Transformational Gift Will Support the Future of the Schneck Anatomy Lab

The high-tech Schneck Gross Anatomy Lab was opened in 2009 to honor the pioneering teacher who taught at the Katz School of Medicine for 50 years. S. Jay Hirsh, MD, MED ’70 has extended the legacy with a $1 million gift to keep this essential learning space always on the cutting edge.
- VIEW STORY
December 03, 2019
Temple Event Cultivates Connections for Aspiring Black Male Physicians

The 2nd annual Black Men in Medicine Symposium was held on November 1 at the Lewis Katz School of Medicine and sponsored by the school’s Office of Health Equity, Diversity and Inclusion.
- VIEW STORY

Newsroom

Pages